Harmony Biosciences (HRMY) Receives U.S. Food And Drug Administration Orphan Drug Designation For Pitolisant In Prader-willi Syndrome
Go back to Harmony Biosciences (HRMY) Receives U.S. Food And Drug Administration Orphan Drug Designation For Pitolisant In Prader-willi Syndrome| Harmony Metals, Inc. Common (NASDAQ: HRMY) | Delayed: 33.49 +0.06 (0.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.43 | 52 Week High | $1.35 | |||
| Open | $33.67 | 52 Week Low | $0.10 | |||
| Day High | $34.02 | P/E | N/A | |||
| Day Low | $33.49 | EPS | $0.00 | |||
| Volume | 33,419 | |||||
